HCM
PFE icon

Hayman Capital Management’s Pfizer PFE Stock Holding History

Hayman Capital Management’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-67,113
Closed -$2.13M – 28
2015
Q2 		$2.13M Buy
+67,113
New +$2.19M 0.25% 33

Other funds holding PFE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Hayman Capital Management's PFE Position: Q3 2015 in Review

Hayman Capital Management sold out of Pfizer (PFE) in Q3 2015, closing a stake of 67,113 shares — an estimated $2.13M sold.

Hayman Capital Management first reported a position in PFE in Q2 2015 and held it in 1 quarter. The position peaked at $2.13M in Q2 2015. 1,879 funds tracked by Wall St. Rank hold PFE as of Q3 2015.

  • Hayman Capital Management reported no remaining Pfizer position as of Q3 2015 after selling out during the quarter.
  • Hayman Capital Management sold 67,113 Pfizer shares in Q3 2015, an estimated $2.13M.
  • Hayman Capital Management first reported a position in Pfizer in Q2 2015 and held it in 1 quarter.
  • Hayman Capital Management's Pfizer position peaked at $2.13M in Q2 2015.
  • 1,879 funds tracked by Wall St. Rank held Pfizer as of Q3 2015.

Based on Hayman Capital Management's 13F filing for Q3 2015, filed 16 Nov 2015.